Evidence for ε-opioid receptor-mediated β-endorphin-induced analgesia

Trends in Pharmacological Sciences

Volumn 22, Issue 12, 2001, Pages 623-630

  Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; 3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA ENDORPHIN; BETA FUNALTREXAMINE; BINALTORPHIMINE; CHOLECYSTOKININ OCTAPEPTIDE; CYCLIC GMP; CYTIDINE TRIPHOSPHATE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DEVAZEPIDE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DIZOCILPINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; EPSILON OPIATE RECEPTOR; GLUTAMATE RECEPTOR; KAPPA OPIATE RECEPTOR; METENKEPHALIN; MORPHINE; MU OPIATE RECEPTOR; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALTRINDOLE; NALTRINDOLE ISOTHIOCYANATE; NITRIC OXIDE; PD 135158; PENTOBARBITAL; PERTUSSIS TOXIN; QUADAZOCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; NARCOTIC ANALGESIC AGENT; OPIATE RECEPTOR;

ANALGESIA; ANTINOCICEPTION; BRAIN REGION; CROSS TOLERANCE; NERVE TRACT; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SWIMMING; TAIL FLICK TEST; ANIMAL; HUMAN; INTRASPINAL DRUG ADMINISTRATION; PHYSIOLOGY;

ANALGESICS, OPIOID; ANIMAL; BETA-ENDORPHIN; HUMAN; INJECTIONS, SPINAL; RECEPTORS, OPIOID; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035529052     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01843-5     Document Type: Review

References (60)

1. κ and ε Opioid receptor binding
2. Mechanisms of β-endorphin-induced antinociception
3. Evidence for the existence of the β-endorphin-sensitive 'ε-opioid receptor' in the brain: The mechanisms of ε-mediated antinociception
4. Opioid receptor selectivity of β-endorphin in vitro and in vivo: μ, δ, and ε receptors
5. The inhibition of the tail-flick response induced by β-endorphin administered intrathecally is mediated by the activation of κ- and μ-opioid receptors in the mouse
6. Antinociceptive effects of intrathecally administered human β-endorphin in the rat and cat
7. Endogenous opioids and addiction
8. Endorphin-induced feeding: Pharmacological characterization using selective opioid antagonists and antisense probes in rats
9. Pharmacological characterization of the ε-opiate receptor
10. 3H]β-endorphin binding in brain
11. Molecular characterization of opioid receptors
12. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered β-endorphin and morphine or DPDPE in mice
13. Partial antinociceptive cross-tolerance to intracerebroventricular β-endorphin in mice tolerant to systemic morphine
14. Brainstem sites differentially sensitive to β-endorphin and morphine for analgesia and the release of Met-enkephalin in anesthetized rats
15. Forebrain sites differentially sensitive to β-endorphin and morphine for analgesia and release of Met-enkephalin in the pentobarbital-anesthetized rat
16. Opioid supraspinal analgesic synergy between the amygdala and periaqueductal gray in rats
17. Supraspinal circuitry mediating opioid antinociception: Antagonist and synergy in multiple sites
18. Biochemical and pharmacological characterization of multiple β-endorphinergic antinociceptive systems in the rat periaqueductal gray
19. Actions of NMDA and cholinergic receptor antagonists in the rostral ventromedial medulla upon β-endorphin analgesia elicited from the ventrolateral periaqueductal gray
20. Endogenous pain control systems: Brainstem spinal pathways and endogenous circuitry
21. Pharmacologic evidence for the modulation of noradrenergic neurons
22. Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats
23. Intrathecal administration of thiorphan and bestatin enhances the antinociception and release of Met-enkephalin induced by β-endorphin injected intraventricularly in anesthetized rats
24. Intrathecal thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by β-endorphin and morphine administered intracerebroventricularly
25. 1 opioid receptors are involved in intracerebroventricular β-endorphin-induced antinociception in the mouse
26. Antisense oligodeoxynucleotide to a δ-opioid receptor given intrathecally blocks i.c.v. administered β-endorphin-induced antinociception in the mouse
27. Evidence for neuropeptide cholecystokinin as an antagonist of opiate analgesia
28. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment
29. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat
30. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat
31. B receptor antagonist L-365,260 in the rat spinal cord
32. Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular β-endorphin-induced antinociception in mice
33. Anti-analgesia and reduced antinociception from supraspinally administered β-endorphin in stressed rats: Dependence on spinal cholecystokinin via cholecystokinin B receptors
34. β-Endorphin administered intraventricularly releases immunoreactive cholecystokinin and Met-enkephalin from the spinal cord in the pentobarbital anesthetized rat
35. Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive Met-enkephalin induced by intraventricular β-endorphin in the rat
36. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin
37. Mechanisms of anticonvulsant drug action
38. Light pentobarbital anesthesia diminishes the antinociceptive potency of morphine administered intracranially but not intrathecally in the rat
39. Pentobarbital anesthesia attenuates inhibition of the tail-flick response induced by morphine but not β-endorphin administered intracerebroventricularly in the mouse
40. Antinociception from the administration of β-endorphin into the periaqueductal gray of rat is enhanced while that of morphine is inhibited by barbiturate anesthesia
41. 2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse
42. Effects of GABA receptor antagonists injected spinally on antinociception induced by opioids administered supraspinally in mice
43. The antinociceptive activity of excitatory amino acids in the rat brainstem: An anatomical and pharmacological analysis
44. 5-enkephalin, and U50,488H administered intracerebroventricularly in mice
45. Nitric oxide: Physiology, physiopathology, and pharmacology
46. Increase of nitric oxide by L-arginine potentiates β-endorphin- but not μ-, δ-, or κ-opioid agonist-induced antinociception in the mouse
47. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and β-endorphin-induced antinociception in the mouse
48. Effects of opioid peptides on peripheral stimulation and 'stress'-induced analgesia in animals
49. Naloxazone and pain-inhibitory systems: Evidence for a collateral inhibition model
50. 2 receptor in the mouse
51. Parallel activation of multiple spinal opiate systems appears to mediate 'non-opiate' stress-induced analgesia
52. 2-opioid receptors in the spinal cord is involved in the cold water swimming-induced antinociception in the mouse
53. Antisense oligodeoxynucleotide to a δ-opioid receptor blocks the antinociception induced by cold water swimming
54. Assessing transient and persistent pain in animals
55. Central β-endorphin system involvement in the reaction to acute tonic pain
56. Nociceptive stimulus induces release of endogenous β-endorphin in the rat brain
57. Antisera against endogenous opioids increase the nocifensive response to formalin: Demonstration of inhibitory β-endorphinergic control
58. Effects of lesion and stimulation of rats hypothalamic arcuate nucleus on the pain system
59. Pretreatment with pertussis toxin differentially modulates morphine- and β-endorphin-induced antinociception in the mouse
60. Pretreatment with pertussis toxin spinally but not supraspinally attenuates cold water swimming-induced antinociception in the mouse